The Trump administration recently celebrated one year of embracing the movement to Make America Healthy Again. Unfortunately, many of these successes are overshadowed by slapdash decision-making at a key health agency, which significantly undermines the administration’s goals, threatens treatment access, choice, and safety for American patients, and hinders our longstanding reputation as a world leader in medical innovation.

For over 100 years, the Food and Drug Administration (FDA) has played a vital role for American patients and drug manufacturers, establishing rigorous, science-based standards and clear approval processes for lifesaving treatments. Prior to this year, the FDA has been considered the “gold standard” among global regulatory bodies. This reputation, however, has been severely diminished during the past year by agency decision-making that has left Americans baffled and concerned.